摩根尼拉
普罗维登西亚
微生物学
生物
放大器
病毒学
抗生素耐药性
细菌遗传学
肠杆菌科
基因
作者
Lamartine Rodrigues Martins,Érica Maria de Oliveira,Maria Izabely Silva Pimentel,Igor Vasconcelos Rocha,Moacir Batista Jucá,Fernanda Gomes Beserra,Reginaldo Gonçalves de Lima Neto,Elizabeth Maria Bispo Beltrão,Ana Catarina de Souza Lopes
标识
DOI:10.1177/10766294261487476
摘要
The genus Providencia and Morganella are part of the World Health Organization (WHO) critical priority pathogens when carbapenem-resistant. This study characterized the molecular epidemiology of carbapenemase genes in 13 clinical isolates of carbapenem-resistant Providencia spp. and Morganella morganii from a Brazilian tertiary hospital. Following species confirmation by MALDI-TOF MS, one of the isolates was reclassified as M. morganii . PCR and amplicon sequencing screened for bla KPC , bla NDM , bla VIM , bla IMP , bla GES , and bla OXA-23 , −24 , −48-LIKE , −51 , −58 , −143 . The bla NDM (11/13, 84.6%) and bla KPC (4/13, 30.8%) were the only carbapenemase genes detected. All isolates tested negative for bla VIM , bla IMP , bla GES , and OXA-type genes. bla NDM-5 was identified in one P. rettgeri and one M. morganii (first reports in Brazil). bla KPC-2 / bla NDM-1 co-occurrence was documented in two P. stuartii isolates. Clinical analysis of bla NDM-5 carriers revealed severe outcomes: one patient self-discharged without targeted therapy, and another died following amputation, extensive antimicrobial exposure, and COVID-19 co-infection. The accumulation of co-expressed resistance mechanisms highlights Providencia spp. and M. morganii as emerging therapeutic challenges.
科研通智能强力驱动
Strongly Powered by AbleSci AI